NCT05892471

Safety and Effectiveness of Ciprofol in Cardiac Surgery Anesthesia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Le Yu · Academic / Other
• Sex: All
• Age: 55 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Ciprofol, a novel intravenous general anesthetic with a chemical structure akin to propofol, boasts significantly enhanced potency. It offers a rapid onset, reduced incidence of injection pain, and minor impact on the cardiovascular system. However, clinical research regarding ciprofol's use for anesthesia induction in cardiac surgery remains limited. The investigators want to assesse the safety and effectiveness of ciprofol in cardiac surgery anesthesia

Conditions

• Anesthesia

Interventions

Type	Name	Description
DRUG	ciprofol injection	Patients in ciprofol group 0.3 mg/kg ciprofol for induction of anesthesia
DRUG	Propofol injection	Patients in propofol group received 1.5 mg/kg propofol for induction of anesthesia

Timeline

• Start date: 2022-08-01
• Primary completion: 2023-08-01
• Completion: 2023-09-01
• First posted: 2023-06-07
• Last updated: 2023-06-07

Locations

1 site across 1 country: China